Skip to content

The Effect of Loss of Offset After Pertrochanteric Fracture Treated With a Intramedullary Nail

The Effect of Loss of Offset After Pertrochanteric Fracture Treated With a Intramedullary Nail

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01344785
Acronym
PLAIN
Enrollment
100
Registered
2011-04-29
Start date
2010-04-30
Completion date
2011-11-30
Last updated
2013-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intertrochanteric Fractures

Keywords

Intertrochanteric Fractures, Intramedullary nailing, Hip function, Pain

Brief summary

The purpose of this study is determine the relationship between pain and protrusion of the implant after surgery for a intertrochanteric fracture.

Detailed description

Intertrochanteric fractures are common fractures in which severe complications such as non-union, implant cut-out and postoperative wound-infections occur at very low rates with modern surgical techniques. While severe complications are rare, the patient reported outcome is less satisfactory with roughly half of the patients complain of thigh pain and others failing to regain their walking ability. The current leading methods for osteosynthesis of intertrochanteric fractures are intramedullary (IM) nails and sliding hip screws (SHS). Over the period 1998 to 2007 the use of IM nails for pertrochanteric fractures increased from 5% to 20% in Sweden, at the expense of the use of SHS (5). IM nailing has also become more common at our clinic where we since February 2008 use the 3rd generation of the Gamma nail. In this study we investigate if the increased pain after IM nailing, reduced hip function and life quality may correlate to the compression over the fracture and the lateral protrusion of the intramedullary nail.

Interventions

All patients will be treated with Intramedullary nailing

Sponsors

Danderyd Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Intertrochanteric Fracture * Age over 55 * Intramedullary nailing

Exclusion criteria

* Severe cognitive impairment * Substance abuse

Design outcomes

Primary

MeasureTime frame
Hip function1 year

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026